Passionate about progress
Passionate about progress
Passionate about progress

 

At SCILEX, we’re excited to develop and commercialize innovative pain management solutions to help improve patient care. Learn more about what’s going on at SCILEX.
 

Investor relations

Based in Malvern, PA, SCILEX Pharmaceuticals specializes in
manufacturing branded treatments to manage acute and chronic pain.

CONTACTS

SCILEX Pharmaceuticals, Inc.
610.644.5352
info@scilexpharma.com

SCILEX news

Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido™ (lidocaine topical system) 1.8% for PHN Pain

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (“Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration (FDA) for ZTlido™ (lidocaine topical system) 1.8%. ZTlido is indicated for the relief of pain associated with post-herpetic neuralgia (PHN), also referred to as … Continue reading Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido™ (lidocaine topical system) 1.8% for PHN Pain


Upcoming events

We’re keeping busy at SCILEX. See where we’ll be next.

Cultivating strong collaborations
Cultivating strong collaborations
Cultivating strong collaborations

Current partnerships

Strong relationships yield promising results. That’s why we’ve cultivated partnerships with some of the best minds in the business. As part of our strategy, SCILEX calls on industry leaders to assist the management team in innovating, manufacturing, developing, marketing, and selling novel products and technologies. Here’s just a sample of the notable partners across all sectors of the pharmaceutical industry with whom we collaborate.

  • Beckloff Associates Cardinal Health
    cGMP Regulatory
  • Clinipace Worldwide
    CRO, Regulatory
  • Lowenstein
    Sandler, LLP

    Outside Legal Counsel
  • Hogan Lovells
    EU Regulatory Counsel
  • BDO USA, LLP
    Auditor
  • Foley & Lardner
    FDA Counsel
  • ITOCHU CHEMICAL FRONTIER Corporation
    ICF, Tokyo, Japan
  • Real Regulatory
    EU Regulatory
X

Share This Page

XS SM MD LG XL